Latest Breaking News On - Josh xu - Page 2 : vimarsana.com

LianBio (LIAN) Reports Results from Phase 3 EXPLORER-CN Trial of Mavacamten

LianBio (LIAN) Reports Results from Phase 3 EXPLORER-CN Trial of Mavacamten
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomSouth koreaHong kongGreat britainJosh xuKatherine smithElizabeth andersonInternational medical departmentUnion medical college hospitalYork heart associationVp communicationsEuropean society of cardiologyExchange commissionEuropean unionBristol myers squibbEuropean society

LianBio Announces Results from Phase 3 EXPLORER-CN Trial of Mavacamten Presented at the European Society of Cardiology Congress and Simultaneous Publication in JAMA Cardiology

LianBio Announces Results from Phase 3 EXPLORER-CN Trial of Mavacamten Presented at the European Society of Cardiology Congress and Simultaneous Publication in JAMA Cardiology
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited kingdomHong kongGreat britainJosh xuElizabeth andersonEuropean unionEuropean society of cardiologyExchange commissionUnion medical college hospitalBristol myers squibbInternational medical departmentYork heart associationVp communicationsEuropean societyNew york heart association

LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Update

LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong kongMacau special administrative regionMacau generalUnited statesJosh xuYizhe wangElizabeth andersonPascal qianKatherine smithAsia pacificClinical development updatesChina national medical products administrationVp communicationsCompany phaseChinese cardiovascular associationExchange commission

LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Mavacamten New Drug Application (NDA) under priority review with China National Medical Products Administration (NMPA)Phase 3 EXPLORER-CN trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) met primary endpointData from EXPLORER-CN trial to be presented in an oral late-breaking science session at European Society of Cardiology Congress 2023Cash, cash equivalents and marketable securities of $267.3 million with runway into the first half of 2025

Hong kongUnited statesMacau special administrative regionMacau generalAsia pacificJosh xuKatherine smithElizabeth andersonPascal qianYizhe wangClinical development updatesChina national medical products administrationEuropean society of cardiologyResearch development expensesEuropean society of cardiology congressChinese cardiovascular association

LianBio Partner Tarsus Pharmaceuticals Announces U S FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0 25% for the Treatment of Demodex Blepharitis

LianBio Partner Tarsus Pharmaceuticals Announces U S FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0 25% for the Treatment of Demodex Blepharitis
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesElizabeth andersonYizhe wangJosh xuVp communicationsDrug administrationTarsus pharmaceuticalsExchange commissionMeibomian gland diseaseMainland chinaChief executive officerNew drug applicationAnnual reportInvestor relations